Status:
COMPLETED
APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Collaborating Sponsors:
Medtronic
Conditions:
Tachyarrhythmia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of APART is the assessment of the therapeutic and preventive stimulation algorithms of the Medtronic AT500 and following devices in patients with atrial tachyarrhythmias and an indication for...
Eligibility Criteria
Inclusion
- Indication for cardiac pacing according to the German guidelines
- Documented (electrocardiogram; ECG) atrial arrhythmia during the last three months before enrollment
- Willingness to terminate antiarrhythmic drugs until the first recurrence of an atrial arrhythmia
- Sinus rhythm during 24 hours before implant of the device
Exclusion
- Ejection fraction below 40%
- Mechanic prosthesis of the tricuspid valve
- Indication to implantable cardioverter defibrillator (ICD)-implantation
- Pregnancy
Key Trial Info
Start Date :
August 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00170274
Start Date
August 1 2000
End Date
October 1 2014
Last Update
July 3 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Segeberger Kliniken
Bad Segeberg, Germany, 23795
2
Kath. Krankenhausgemeinschaft GmbH, Philippusstift Essen
Essen, Germany, 45355
3
Krankenhaus Marienhof
Koblenz, Germany, 56056
4
Klinikum der Stadt Ludwigshafen
Ludwigshafen, Germany, 67063